Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Afrocentric InvestmentJSE:ACT +10.39%54 EV-to-OCF is 1.25 as of Aug. 11, 2026, which is 87% below its 10-year median of 9.99. GuruFocus rates JSE:ACT with a GF Score™ of 54/100 and a GF Value™ of R2.04 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Afrocentric Investment ranks better than 69.75% on this metric.
The historical rank and industry rank for Afrocentric Investment's EV-to-OCF or its related term are showing as below:
JSE:ACT'
s EV-to-OCF Range Over the Past 10 Years
Min: 1.1 Med: 9.99 Max: 20.79
Current: 1.25
During the past 13 years, the highest EV-to-OCF of Afrocentric Investment was 20.79. The lowest was 1.10. And the median was 9.99.
JSE:ACT's EV-to-OCF is ranked better than 69.75% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 8.95
vs JSE:ACT: 1.25
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Afrocentric Investment's PE Ratio (TTM) for today is calculated as:
Afrocentric Investment's share price for today is R0.85.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Afrocentric Investment's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was R-1.519.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Afrocentric Investment's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Afrocentric Investment EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Afrocentric Investment's EV-to-OCF falls into.
Afrocentric Investment's current Enterprise Value is R853 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Afrocentric Investment's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was R685 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Afrocentric Investment (JSE:ACT) has a EV-to-OCF of 1.25 as of Aug. 11, 2026. This is 87% below median its historical median of 9.99. Over the past decade, Afrocentric Investment's EV-to-OCF has ranged from 1.10 to 20.79. According to the industry distribution chart, Afrocentric Investment ranks #206 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 30.2%.
Is Afrocentric Investment's EV-to-OCF too high?
Afrocentric Investment's current EV-to-OCF of 1.25 is 87% below median its 10-year median of 9.99. Over the past 10 years, this metric has ranged from a low of 1.10 to a high of 20.79. The Healthcare Providers & Services industry median EV-to-OCF is 8.95. Afrocentric Investment's value of 1.25 is 86% below this industry median. Based on the distribution chart, Afrocentric Investment ranks #206 out of 681 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Afrocentric Investment has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Afrocentric Investment's EV-to-OCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Afrocentric Investment ranks #206 out of 681 companies for EV-to-OCF. This puts Afrocentric Investment in the upper half of its industry. The industry median EV-to-OCF is 8.95. Afrocentric Investment's value of 1.25 is 86% below this benchmark. Historically, Afrocentric Investment's own EV-to-OCF has ranged from 1.10 to 20.79 over the past decade. While the company's 10-year median is 9.99 vs. the industry median of 8.95, Afrocentric Investment has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.95, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Afrocentric Investment's current EV-to-OCF of 1.25 is 86% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Afrocentric Investment's current EV-to-OCF is 1.25, which is 87% below median its own 10-year median of 9.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afrocentric Investment stock overvalued right now?
Based on GuruFocus' analysis, Afrocentric Investment (JSE:ACT) is currently considered Possible Value Trap. The stock's GF Value™ is R2.04, compared to a current price of R0.85 — trading 58.3% below its estimated fair value. The current EV-to-OCF is 1.25, which is 87% below median its 10-year median of 9.99 and 86% below the Healthcare Providers & Services industry median of 8.95. Afrocentric Investment's overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Afrocentric Investment (JSE:ACT), the current EV-to-OCF is 1.25 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Afrocentric Investment (JSE:ACT) Overvalued in 2026?
Based on GuruFocus' analysis, Afrocentric Investment stock appears to be undervalued.
The current stock price of R0.85 is trading 58.3% below its estimated GF Value™ of R2.04.
GuruFocus considers Afrocentric Investment to be Possible Value Trap.
Key valuation signals for JSE:ACT:
EV-to-OCF: 1.25 (87% below median its 10-year median of 9.99)
GF Value™: R2.04 vs. price of R0.85 (58.3% below fair value)
Industry Position: 86% below the Healthcare Providers & Services median (#206 of 681)
No single metric tells the full story. See the JSE:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Afrocentric Investment Corp Ltd is an investment holding company providing specialised services and products to the public and private healthcare sectors. It focuses on making quality healthcare accessible and affordable to members and beneficiaries, with the principal objective of ensuring the delivery of efficient health management services and the distribution of quality products. Its business segments include Healthcare SA, comprising medical scheme administration and health risk management services; Healthcare Retail, comprising pharmaceutical sales and services; Healthcare Africa, comprising healthcare services outside South Africa in Namibia and Mauritius; and IT-related services predominantly within South Africa. It operates across South Africa, Botswana, Mauritius, and Namibia.
54GF Score
Get the complete analysis for JSE:ACT
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:ACT has been successfully added to your 
